Literature DB >> 10729750

Sodium restriction decreases AP-1 activation after nephron reduction in the rat: role in the progression of renal lesions.

F Terzi1, M Burtin, M Hekmati, C Jouanneau, H Beaufils, G Friedlander.   

Abstract

Renal hyperplasia and hypertrophy are early events after nephron reduction which precede progressive destruction of the remnant kidney. Restriction of dietary sodium content was shown to reduce renal lesions following nephron reduction. AP-1 is a transcription factor, resulting from heterodimerization of fos and jun proteins, which mediates the effects of mitogenic growth factors. To elucidate the role of AP-1 in growth processes involved in renal deterioration, we evaluated whether restriction of dietary sodium content (0.25 vs. 0.50% sodium w/w) affected AP-1-DNA binding and hyperplasia in the remnant kidney after nephron reduction (70% nephrectomy). Cell proliferation, evaluated by PCNA immunostaining, increased progressively from day 7 to day 60 in glomeruli, proximal and distal tubules and loops of Henle of nephrectomized (Nx) rats compared to control sham-operated (C) animals. AP-1-DNA binding activity increased 7 and 14 days after surgery, but it was reduced below C values at day 60. c-fos and c-jun expression were also reduced in Nx rats at day 60. Sodium restriction significantly reduced the number of PCNA-stained cells in glomeruli and tubules at days 14 and 60, but not at day 7, whereas it decreased AP-1 activation at all times of the study. This effect was associated to a marked reduction of renal lesions in Nx rats. In conclusion, we showed that, after nephron reduction, the beneficial effect of sodium restriction was associated with a reduction of hyperplasia and AP-1 activation, but that the latter did not parallel delayed cell proliferation rate in remaining nephrons. Thus, we propose that different transduction pathways are involved in cell proliferation after nephron reduction, according to the time of evolution of renal lesions. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10729750     DOI: 10.1159/000020656

Source DB:  PubMed          Journal:  Exp Nephrol        ISSN: 1018-7782


  6 in total

1.  Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury.

Authors:  F Terzi; M Burtin; M Hekmati; P Federici; G Grimber; P Briand; G Friedlander
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

2.  Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions.

Authors:  E Pillebout; M Burtin; H T Yuan; P Briand; A S Woolf; G Friedlander; F Terzi
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

3.  JunD protects against chronic kidney disease by regulating paracrine mitogens.

Authors:  Evangéline Pillebout; Jonathan B Weitzman; Martine Burtin; Carla Martino; Pierre Federici; Moshe Yaniv; Gérard Friedlander; Fabiola Terzi
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

4.  Effects of 5/6 nephrectomy on renal function and blood pressure in mice.

Authors:  Agata L Gava; Flavia Ps Freitas; Camille M Balarini; Elisardo C Vasquez; Silvana S Meyrelles
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-09-20

5.  A transcriptional network underlies susceptibility to kidney disease progression.

Authors:  Denise Laouari; Martine Burtin; Aurélie Phelep; Frank Bienaime; Laure-Hélène Noel; David C Lee; Christophe Legendre; Gérard Friedlander; Marco Pontoglio; Fabiola Terzi
Journal:  EMBO Mol Med       Date:  2012-06-18       Impact factor: 12.137

6.  Determination of the dynamic cellular transcriptional profiles during kidney development from birth to maturity in rats by single-cell RNA sequencing.

Authors:  Fangrui Ding; Xiuying Tian; Jiali Mo; Botao Wang; Jun Zheng
Journal:  Cell Death Discov       Date:  2021-06-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.